Orbimed Advisors Takes a Major Stake in Ambit Biosciences Corp (AMBI)

Page 2 of 2

In Pfizer Inc. (NYSE:PFE), Orbimed Advisors holds about 9.2 million shares, the value of the stake being reported of some $266.1 million. In  Biogen Idec Inc. (NASDAQ:BIIB), and Merck & Co., Inc. (NYSE:MRK), the hedge fund managed by Samuel Isaly owns 709,800 shares and about 2.2 million shares respectively. The value of the last two mentioned stakes amounts to $136.7 million and $98 million respectively.

With that being said, Insider Monkey will keep you in the loop regarding the smart money’s investment plays surrounding Ambit Biosciences Corp (NASDAQ:AMBI).

Page 2 of 2